Androgen receptor interactions provide insight into steroid mediated metabolic shifts in endocrine resistant breast cancer.
Rachel Bleach, Emir Bozkurt, Jingqi Xin, Katherine M. Sheehan, Sally L. Shirran, Stephanie Agbana, Mihaela Ola, Leonie S. Young, Nicole S. Spoelstra, Jennifer K. Richer, Ana Cristina Vargas, Leonard D. Goldstein, Heloisa Helena Milioli, Christine Louise Chaffer, Michael O’Reilly, , Marie McIlroy
This study identifies cytoplasmic androgen receptor (AR) localization and novel AR protein interactions in AI-resistant breast cancer, linking them to metabolic shifts and poor prognosis.
npj Breast Cancer · Mar 17, 2026Peer-reviewedCancer Biology